Literature DB >> 21984209

Crystal structures of the extracellular domain of LRP6 and its complex with DKK1.

Zhihong Cheng1, Travis Biechele, Zhiyi Wei, Seamus Morrone, Randall T Moon, Liguo Wang, Wenqing Xu.   

Abstract

Low-density-lipoprotein (LDL) receptor-related proteins 5 and 6 (LRP5/6) are Wnt co-receptors essential for Wnt/β-catenin signaling. Dickkopf 1 (DKK1) inhibits Wnt signaling by interacting with the extracellular domains of LRP5/6 and is a drug target for multiple diseases. Here we present the crystal structures of a human LRP6-E3E4-DKK1 complex and the first and second halves of human LRP6's four propeller-epidermal growth factor (EGF) pairs (LRP6-E1E2 and LRP6-E3E4). Combined with EM analysis, these data demonstrate that LRP6-E1E2 and LRP6-E3E4 form two rigid structural blocks, with a short intervening hinge that restrains their relative orientation. The C-terminal domain of DKK1 (DKK1c) interacts with the top surface of the LRP6-E3 YWTD propeller and given their structural similarity, probably also that of the LRP6-E1 propeller, through conserved hydrophobic patches buttressed by a network of salt bridges and hydrogen bonds. Our work provides key insights for understanding LRP5/6 structure and the interaction of LRP5/6 with DKK, as well as for drug discovery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984209      PMCID: PMC3249237          DOI: 10.1038/nsmb.2139

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  54 in total

Review 1.  Parameters of LRP5 from a structural and molecular perspective.

Authors:  Mark L Johnson; Douglas T Summerfield
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2005       Impact factor: 1.807

2.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

3.  LRP6 mutation in a family with early coronary disease and metabolic risk factors.

Authors:  Arya Mani; Jayaram Radhakrishnan; He Wang; Alaleh Mani; Mohammad-Ali Mani; Carol Nelson-Williams; Khary S Carew; Shrikant Mane; Hossein Najmabadi; Dan Wu; Richard P Lifton
Journal:  Science       Date:  2007-03-02       Impact factor: 47.728

4.  Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins.

Authors:  Barbara K Brott; Sergei Y Sokol
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.

Authors:  Yan Gong; Eric Bourhis; Cecilia Chiu; Scott Stawicki; Venita I DeAlmeida; Bob Y Liu; Khanhky Phamluong; Tim C Cao; Richard A D Carano; James A Ernst; Mark Solloway; Bonnee Rubinfeld; Rami N Hannoush; Yan Wu; Paul Polakis; Mike Costa
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

Review 7.  The role of Dickkopf-1 in bone development, homeostasis, and disease.

Authors:  Joseph J Pinzone; Brett M Hall; Nanda K Thudi; Martin Vonau; Ya-Wei Qiang; Thomas J Rosol; John D Shaughnessy
Journal:  Blood       Date:  2008-08-07       Impact factor: 22.113

8.  Targeted disruption of the Wnt regulator Kremen induces limb defects and high bone density.

Authors:  Kristina Ellwanger; Hiroaki Saito; Philippe Clément-Lacroix; Nicole Maltry; Joachim Niedermeyer; Woon Kyu Lee; Roland Baron; Georges Rawadi; Heiner Westphal; Christof Niehrs
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

Review 9.  Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone.

Authors:  Bart O Williams; Karl L Insogna
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  77 in total

1.  Cell signaling. Crystallizing WNT signalling.

Authors:  Katharine H Wrighton
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01       Impact factor: 94.444

2.  Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.

Authors:  Gill Holdsworth; Patrick Slocombe; Carl Doyle; Bernadette Sweeney; Vaclav Veverka; Kelly Le Riche; Richard J Franklin; Joanne Compson; Daniel Brookings; James Turner; Jeffery Kennedy; Rachael Garlish; Jiye Shi; Laura Newnham; David McMillan; Mariusz Muzylak; Mark D Carr; Alistair J Henry; Thomas Ceska; Martyn K Robinson
Journal:  J Biol Chem       Date:  2012-06-13       Impact factor: 5.157

3.  Structural basis of agrin-LRP4-MuSK signaling.

Authors:  Yinong Zong; Bin Zhang; Shenyan Gu; Kwangkook Lee; Jie Zhou; Guorui Yao; Dwight Figueiredo; Kay Perry; Lin Mei; Rongsheng Jin
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

4.  Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease.

Authors:  Roshni Srivastava; Jiasheng Zhang; Gwang-Woong Go; Anand Narayanan; Timothy P Nottoli; Arya Mani
Journal:  Cell Rep       Date:  2015-10-17       Impact factor: 9.423

5.  The Wnt Antagonist Dickkopf-1 Promotes Pathological Type 2 Cell-Mediated Inflammation.

Authors:  Wook-Jin Chae; Allison K Ehrlich; Pamela Y Chan; Alexandra M Teixeira; Octavian Henegariu; Liming Hao; Jae Hun Shin; Jong-Hyun Park; Wai Ho Tang; Sang-Taek Kim; Stephen E Maher; Karen Goldsmith-Pestana; Peiying Shan; John Hwa; Patty J Lee; Diane S Krause; Carla V Rothlin; Diane McMahon-Pratt; Alfred L M Bothwell
Journal:  Immunity       Date:  2016-02-09       Impact factor: 31.745

Review 6.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

Review 7.  Three decades of Wnts: a personal perspective on how a scientific field developed.

Authors:  Roel Nusse; Harold Varmus
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

Review 8.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

Review 9.  The way Wnt works: components and mechanism.

Authors:  Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee
Journal:  Growth Factors       Date:  2012-12-21       Impact factor: 2.511

Review 10.  LRP5 and LRP6 in development and disease.

Authors:  Danese M Joiner; Jiyuan Ke; Zhendong Zhong; H Eric Xu; Bart O Williams
Journal:  Trends Endocrinol Metab       Date:  2013-01       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.